| Texas Elite Health Clinic, Llc | |
|
1304 Village Creek Dr Suite 300-b Plano TX 75093-4472 | |
| (972) 402-9700 | |
| (972) 402-9706 |
| Full Name | Texas Elite Health Clinic, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1304 Village Creek Dr, Plano, Texas |
| Authorized Official Name and Position | Julie Kay Powell (FAMILY NURSE PRACTITIONER) |
| Authorized Official Contact | 9724029700 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Texas Elite Health Clinic, Llc Po Box 116762 Carrollton TX 75011-6762 Ph: (972) 402-9700 | Texas Elite Health Clinic, Llc 1304 Village Creek Dr Suite 300-b Plano TX 75093-4472 Ph: (972) 402-9700 |
| NPI Number | 1033499967 |
|---|---|
| Provider Enumeration Date | 08/23/2011 |
| Last Update Date | 09/17/2012 |
| Medicare PECOS PAC ID | 0547435968 |
|---|---|
| Medicare Enrollment ID | O20111214000454 |
News Archive
Tranquil living environments can positively affect the human brain function, according to researchers at the University of Sheffield. The research, which was published in the journal NeuroImage, uses functional brain imaging to assess how the environment impacts upon our brain functions.
After over a century of development, cancer immunotherapy (CIT) has risen to become a promising approach for treating cancer. Unlike conventional methods that try to kill cancer cells directly, CIT involves modifying or stimulating the immune system's natural ability to fight the disease. So far, various CIT treatments have shown remarkable results in terms of survival rates, and many new and combination strategies are currently under study.
A study by global health service company Cigna Corporation (NYSE: CI) shows that individuals whose medical, behavioral and pharmacy health benefits are connected and administered by Cigna are more engaged in their health and well-being than those whose benefits are not fully integrated across medical, behavioral and pharmacy.
Scientists at The Scripps Research Institute have caught a cancer-causing mutation in the act. A new study shows how a gene mutation found in several human cancers, including leukemia, gliomas and melanoma, promotes the growth of aggressive tumors.
GlySens Incorporated announced today that it has secured FDA approval for extending the current human clinical evaluation of its fully implantable continuous glucose monitoring system (the ICGM System) from the originally approved six-month duration to the system's commercially-intended operational duration of twelve months.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033499967 | NPI | - | NPPES |
| 2971285-01 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | 774439 (Texas) | Primary |
| Provider Name | Julie K Powell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467495465 PECOS PAC ID: 0042123309 Enrollment ID: I20111214000484 |
News Archive
Tranquil living environments can positively affect the human brain function, according to researchers at the University of Sheffield. The research, which was published in the journal NeuroImage, uses functional brain imaging to assess how the environment impacts upon our brain functions.
After over a century of development, cancer immunotherapy (CIT) has risen to become a promising approach for treating cancer. Unlike conventional methods that try to kill cancer cells directly, CIT involves modifying or stimulating the immune system's natural ability to fight the disease. So far, various CIT treatments have shown remarkable results in terms of survival rates, and many new and combination strategies are currently under study.
A study by global health service company Cigna Corporation (NYSE: CI) shows that individuals whose medical, behavioral and pharmacy health benefits are connected and administered by Cigna are more engaged in their health and well-being than those whose benefits are not fully integrated across medical, behavioral and pharmacy.
Scientists at The Scripps Research Institute have caught a cancer-causing mutation in the act. A new study shows how a gene mutation found in several human cancers, including leukemia, gliomas and melanoma, promotes the growth of aggressive tumors.
GlySens Incorporated announced today that it has secured FDA approval for extending the current human clinical evaluation of its fully implantable continuous glucose monitoring system (the ICGM System) from the originally approved six-month duration to the system's commercially-intended operational duration of twelve months.
› Verified 6 days ago
News Archive
Tranquil living environments can positively affect the human brain function, according to researchers at the University of Sheffield. The research, which was published in the journal NeuroImage, uses functional brain imaging to assess how the environment impacts upon our brain functions.
After over a century of development, cancer immunotherapy (CIT) has risen to become a promising approach for treating cancer. Unlike conventional methods that try to kill cancer cells directly, CIT involves modifying or stimulating the immune system's natural ability to fight the disease. So far, various CIT treatments have shown remarkable results in terms of survival rates, and many new and combination strategies are currently under study.
A study by global health service company Cigna Corporation (NYSE: CI) shows that individuals whose medical, behavioral and pharmacy health benefits are connected and administered by Cigna are more engaged in their health and well-being than those whose benefits are not fully integrated across medical, behavioral and pharmacy.
Scientists at The Scripps Research Institute have caught a cancer-causing mutation in the act. A new study shows how a gene mutation found in several human cancers, including leukemia, gliomas and melanoma, promotes the growth of aggressive tumors.
GlySens Incorporated announced today that it has secured FDA approval for extending the current human clinical evaluation of its fully implantable continuous glucose monitoring system (the ICGM System) from the originally approved six-month duration to the system's commercially-intended operational duration of twelve months.
› Verified 6 days ago
Family Medicine At Willow Bend Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5944 W Parker Rd, Suite 100, Plano, TX 75093 Phone: 972-608-1868 Fax: 972-943-8644 | |
Segal Family Medicine Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6537 Preston Rd, Plano, TX 75024 Phone: 972-379-2096 Fax: 972-379-2054 | |
Michelle Sun Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3900 W 15th St, Suite 404, Plano, TX 75075 Phone: 972-758-9327 Fax: 972-867-4970 | |
William R Sheldon, Jr., Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5930 W Parker Rd, #700, Plano, TX 75093 Phone: 972-943-7626 Fax: 972-608-5223 | |
Michael C Martin Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6020 W Parker Rd Ste 420, Plano, TX 75093 Phone: 972-244-1300 | |
Sireesha Janga Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3517 Enclave Trl, Plano, TX 75074 Phone: 972-322-7965 Fax: 972-325-5291 | |
Nortex Integrated Medicine Pllc - Dallas Series Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7000 Preston Rd Ste 1500, Plano, TX 75024 Phone: 972-872-8408 Fax: 972-850-7352 |